Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gottesman

Showing results (551-560 of 602) with videos related to

Pageof 61
Sort By:
Pharmacogenomics|December 26, 2006
Ethnicity-related polymorphisms and haplotypes in the human ABCB1 geneChava Kimchi-Sarfaty, Andrew H Marple, Shiri Shinar, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
The Multidrug Resistance Transporter P-glycoprotein Confers Resistance to Ferroptosis InducersWilliam J E Frye, Lyn M Huff, José M González Dalmasy, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter <i>SLC43A1</i> (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cellsN R Pawar, H M Wade, Z Jackson, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducersWilliam J E Frye, Lyn M Huff, José M González Dalmasy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 10, 2010
N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrierPavitra Kannan, Kyle R Brimacombe, Sami S Zoghbi, et al.
Molecular Cancer Therapeutics|June 2, 2026
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cellsNisha R Pawar, Heidi M Wade, Zoe Jackson, et al.
Cancer Research|May 3, 2006
Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancerJoseph A Ludwig, Gergely Szakács, Scott E Martin, et al.
Molecular Cancer Therapeutics|July 9, 2009
Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery databaseJosiah N Orina, Anna Maria Calcagno, Chung-Pu Wu, et al.
Biochemistry|January 29, 2016
Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1)Kristen M Pluchino, Matthew D Hall, Janna K Moen, et al.
Molecular Pharmacology|May 19, 2016
Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic CycleGabriel A Frank, Suneet Shukla, Prashant Rao, et al.
Pageof 61

Showing results (551-560 of 602) with videos related to

Sort By:
Pageof 61
Pharmacogenomics|December 26, 2006
Ethnicity-related polymorphisms and haplotypes in the human ABCB1 geneChava Kimchi-Sarfaty, Andrew H Marple, Shiri Shinar, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
The Multidrug Resistance Transporter P-glycoprotein Confers Resistance to Ferroptosis InducersWilliam J E Frye, Lyn M Huff, José M González Dalmasy, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter <i>SLC43A1</i> (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cellsN R Pawar, H M Wade, Z Jackson, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducersWilliam J E Frye, Lyn M Huff, José M González Dalmasy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 10, 2010
N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrierPavitra Kannan, Kyle R Brimacombe, Sami S Zoghbi, et al.
Molecular Cancer Therapeutics|June 2, 2026
A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cellsNisha R Pawar, Heidi M Wade, Zoe Jackson, et al.
Cancer Research|May 3, 2006
Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancerJoseph A Ludwig, Gergely Szakács, Scott E Martin, et al.
Molecular Cancer Therapeutics|July 9, 2009
Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery databaseJosiah N Orina, Anna Maria Calcagno, Chung-Pu Wu, et al.
Biochemistry|January 29, 2016
Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1)Kristen M Pluchino, Matthew D Hall, Janna K Moen, et al.
Molecular Pharmacology|May 19, 2016
Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic CycleGabriel A Frank, Suneet Shukla, Prashant Rao, et al.
Pageof 61